Abstract
Treatment for an enterovaginal fistula should consider the location of an intestinal fistula. Most rectovaginal fistulas develop in the lower third of the vagina and can be treated surgically. Jejunovaginal fistulas can spontaneously close during conservative management. We report the first use of the Amplatzer vascular plug II (AVP II; AGA Medical Corp, Golden Valley, MN, USA) and the use of an N-butyl-2-cyanoacrylate (NBCA; Histoacryl, Braun, Melsungen, Germany)- iodized oil (Lipiodol Ultra-Fluid, Guerbet, Aulnay-sous-Bois, France) mixture for treatment of a patient with a jejunovaginal fistula which failed to close after conservative management. The patient did not have any vaginal discharge one day later after deployment of the AVP II.
장질루(Endovaginal fistula)의 치료는 질과 연결된 장의 위치에 따라 결정된다. 직장질루(rectovaginal fistula)의 경우 대부분은 질의 하부 1/3에서 발생하고 수술적으로 치료되며 공장질루(jejunovaginal fistula)의 경우 종종 보존적 치료만으로 자연 폐쇄된다. 저자들은 보존적 치료로 호전되지 않는 공장질루를 Amplatzer 혈관폐색장치 II(AVP II; AGA Medical Corp., Golden Valley, MN, USA) 및 N-butyl-2-cyanoacrylate (NBCA; Histoacryl, Braun, Melsungen, Germany)- 요드화유(Lipiodol Ultra-Fluid, Guerbet, Aulnay-sous-Bois, France) 혼합물을 이용하여 성공적으로 치료한 예를 경험하였기에 보고한다.